These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 24438238)
21. MicroRNA expression patterns in the malignant progression of gliomas and a 5-microRNA signature for prognosis. Yan W; Li R; Liu Y; Yang P; Wang Z; Zhang C; Bao Z; Zhang W; You Y; Jiang T Oncotarget; 2014 Dec; 5(24):12908-15. PubMed ID: 25415048 [TBL] [Abstract][Full Text] [Related]
22. Upregulation of miR-181s reverses mesenchymal transition by targeting KPNA4 in glioblastoma. Wang H; Tao T; Yan W; Feng Y; Wang Y; Cai J; You Y; Jiang T; Jiang C Sci Rep; 2015 Aug; 5():13072. PubMed ID: 26283154 [TBL] [Abstract][Full Text] [Related]
23. Molecular subtypes of pancreatic cancer based on miRNA expression profiles have independent prognostic value. Namkung J; Kwon W; Choi Y; Yi SG; Han S; Kang MJ; Kim SW; Park T; Jang JY J Gastroenterol Hepatol; 2016 Jun; 31(6):1160-7. PubMed ID: 26644397 [TBL] [Abstract][Full Text] [Related]
24. Identification of prognostic biomarkers in glioblastoma using a long non-coding RNA-mediated, competitive endogenous RNA network. Cao Y; Wang P; Ning S; Xiao W; Xiao B; Li X Oncotarget; 2016 Jul; 7(27):41737-41747. PubMed ID: 27229531 [TBL] [Abstract][Full Text] [Related]
25. A novel microRNAs expression signature for hepatocellular carcinoma diagnosis and prognosis. Lu M; Kong X; Wang H; Huang G; Ye C; He Z Oncotarget; 2017 Jan; 8(5):8775-8784. PubMed ID: 28060739 [TBL] [Abstract][Full Text] [Related]
26. A novel prognostic six-CpG signature in glioblastomas. Yin AA; Lu N; Etcheverry A; Aubry M; Barnholtz-Sloan J; Zhang LH; Mosser J; Zhang W; Zhang X; Liu YH; He YL CNS Neurosci Ther; 2018 Mar; 24(3):167-177. PubMed ID: 29350455 [TBL] [Abstract][Full Text] [Related]
27. MicroRNA expression signatures and their correlation with clinicopathological features in glioblastoma multiforme. Henriksen M; Johnsen KB; Olesen P; Pilgaard L; Duroux M Neuromolecular Med; 2014 Sep; 16(3):565-77. PubMed ID: 24817689 [TBL] [Abstract][Full Text] [Related]
28. A 4-miRNAs signature predicts survival in glioblastoma multiforme patients. Yuan GQ; Wei NL; Mu LY; Wang XQ; Zhang YN; Zhou WN; Pan YW Cancer Biomark; 2017 Dec; 20(4):443-452. PubMed ID: 28869437 [TBL] [Abstract][Full Text] [Related]
29. Comprehensive analysis of Reverse Phase Protein Array data reveals characteristic unique proteomic signatures for glioblastoma subtypes. Patil V; Mahalingam K Gene; 2019 Feb; 685():85-95. PubMed ID: 30401645 [TBL] [Abstract][Full Text] [Related]
30. Downregulation of serum microRNA-205 as a potential diagnostic and prognostic biomarker for human glioma. Yue X; Lan F; Hu M; Pan Q; Wang Q; Wang J J Neurosurg; 2016 Jan; 124(1):122-8. PubMed ID: 26230475 [TBL] [Abstract][Full Text] [Related]
31. Prediction of clinical outcome in glioblastoma using a biologically relevant nine-microRNA signature. Hayes J; Thygesen H; Tumilson C; Droop A; Boissinot M; Hughes TA; Westhead D; Alder JE; Shaw L; Short SC; Lawler SE Mol Oncol; 2015 Mar; 9(3):704-14. PubMed ID: 25499534 [TBL] [Abstract][Full Text] [Related]
32. miR-181d/MALT1 regulatory axis attenuates mesenchymal phenotype through NF-κB pathways in glioblastoma. Yang F; Liu X; Liu Y; Liu Y; Zhang C; Wang Z; Jiang T; Wang Y Cancer Lett; 2017 Jun; 396():1-9. PubMed ID: 28286260 [TBL] [Abstract][Full Text] [Related]
33. Prognostic risk model construction and molecular marker identification in glioblastoma multiforme based on mRNA/microRNA/long non-coding RNA analysis using random survival forest method. Wang H; Liu D; Yang J Neoplasma; 2019 May; 66(3):459-469. PubMed ID: 30784292 [TBL] [Abstract][Full Text] [Related]
34. Unique genome-wide map of TCF4 and STAT3 targets using ChIP-seq reveals their association with new molecular subtypes of glioblastoma. Zhang JX; Zhang J; Yan W; Wang YY; Han L; Yue X; Liu N; You YP; Jiang T; Pu PY; Kang CS Neuro Oncol; 2013 Mar; 15(3):279-89. PubMed ID: 23295773 [TBL] [Abstract][Full Text] [Related]
35. Genetic and clinical characteristics of primary and secondary glioblastoma is associated with differential molecular subtype distribution. Li R; Li H; Yan W; Yang P; Bao Z; Zhang C; Jiang T; You Y Oncotarget; 2015 Mar; 6(9):7318-24. PubMed ID: 25821160 [TBL] [Abstract][Full Text] [Related]
36. Identification of a multidimensional transcriptome signature for survival prediction of postoperative glioblastoma multiforme patients. Gao WZ; Guo LM; Xu TQ; Yin YH; Jia F J Transl Med; 2018 Dec; 16(1):368. PubMed ID: 30572911 [TBL] [Abstract][Full Text] [Related]
37. MiR-330-3p and miR-485-5p as biomarkers for glioblastoma: An integrated bioinformatics and experimental study. Rahmati Y; Alivand M; Mollanoori H Comput Biol Chem; 2021 Jun; 92():107458. PubMed ID: 33761401 [TBL] [Abstract][Full Text] [Related]
38. Prognostic value of a microRNA signature as a novel biomarker in patients with lower-grade gliomas. Qian Z; Li Y; Fan X; Zhang C; Wang Y; Jiang T; Liu X J Neurooncol; 2018 Mar; 137(1):127-137. PubMed ID: 29204839 [TBL] [Abstract][Full Text] [Related]
39. Serum microRNA profiling in patients with glioblastoma: a survival analysis. Zhao H; Shen J; Hodges TR; Song R; Fuller GN; Heimberger AB Mol Cancer; 2017 Mar; 16(1):59. PubMed ID: 28284220 [TBL] [Abstract][Full Text] [Related]
40. Identification of prognostic gene signatures of glioblastoma: a study based on TCGA data analysis. Kim YW; Koul D; Kim SH; Lucio-Eterovic AK; Freire PR; Yao J; Wang J; Almeida JS; Aldape K; Yung WK Neuro Oncol; 2013 Jul; 15(7):829-39. PubMed ID: 23502430 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]